{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_voxels","feature":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","contains":"claim voxels + source edges","slug":"tirzepatide-carpal-tunnel","urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/voxels","write":"https://miscsubjects.com/api/protocol/claim"},"how_to_use":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","write":"https://miscsubjects.com/api/protocol/claim","imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"constitution","name":"Article constitution","what":"Binding rules: required article slots, claim/source rules, ontology anti-sprawl.","urls":{"read":"https://miscsubjects.com/api/articles/constitution","read_md":"https://miscsubjects.com/api/articles/constitution?format=markdown"}},{"id":"sources_ledger","name":"Source ledger","what":"Hash-chained cited sources; verify integrity at GET .../sources.","urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/sources","write":"https://miscsubjects.com/api/protocol/sources"}},{"id":"claim_post","name":"Claim post protocol","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by.","urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","why":"Every feature is auditable collective intelligence","how":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/voxels","write":"https://miscsubjects.com/api/protocol/claim"},"imessage":null,"router":null,"related":[{"id":"constitution","what":"Binding rules: required article slots, claim/source rules, ontology anti-sprawl."},{"id":"sources_ledger","what":"Hash-chained cited sources; verify integrity at GET .../sources."},{"id":"claim_post","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by."}],"not_medical_advice":true},"position":{"you_are_here":"https://miscsubjects.com/a/tirzepatide-carpal-tunnel — Tirzepatide for Carpal Tunnel Syndrome: Weight-Loss Mechanism and Evidence Review","plane":"tirzepatide","master_entry":"https://miscsubjects.com/a/philosophy","siblings":[{"slug":"tirzepatide","title":"tirzepatide","url":"https://miscsubjects.com/a/tirzepatide"},{"slug":"tirzepatide-benzo-withdrawal","title":"Tirzepatide and Benzodiazepine Withdrawal: A Data-First Evidence Review","url":"https://miscsubjects.com/a/tirzepatide-benzo-withdrawal"},{"slug":"tirzepatide-benzodiazepines","title":"Tirzepatide and Benzodiazepines: Metabolic Load, Absorption Effects, and Repair vs Suppression Framing","url":"https://miscsubjects.com/a/tirzepatide-benzodiazepines"},{"slug":"tirzepatide-brain-fog","title":"Tirzepatide for Statin-Associated Cognitive Effects: Evidence Layers and Repair Pathways","url":"https://miscsubjects.com/a/tirzepatide-brain-fog"},{"slug":"tirzepatide-chemo","title":"Tirzepatide and Gabapentin/Pregabalin in the Context of Chemotherapy: Evidence on Load, Symptoms, and Repair Pathways","url":"https://miscsubjects.com/a/tirzepatide-chemo"},{"slug":"tirzepatide-chemo-neuropathy","title":"Tirzepatide for Chemotherapy-Induced Neuropathy: Evidence Review","url":"https://miscsubjects.com/a/tirzepatide-chemo-neuropathy"},{"slug":"tirzepatide-cognition","title":"Tirzepatide for Cognition","url":"https://miscsubjects.com/a/tirzepatide-cognition"},{"slug":"tirzepatide-corticosteroids","title":"Tirzepatide and Corticosteroid Injections: Metabolic Load Reduction vs. Inflammatory Suppression Evidence","url":"https://miscsubjects.com/a/tirzepatide-corticosteroids"},{"slug":"tirzepatide-diabetic-neuropathy","title":"Tirzepatide for Diabetic Neuropathy: Evidence on Metabolic Pathways","url":"https://miscsubjects.com/a/tirzepatide-diabetic-neuropathy"},{"slug":"tirzepatide-frozen-shoulder","title":"Tirzepatide for Frozen Shoulder: Metabolic Load and Evidence Review","url":"https://miscsubjects.com/a/tirzepatide-frozen-shoulder"},{"slug":"tirzepatide-gabapentin","title":"Tirzepatide and Gabapentin: Evidence on Their Cross","url":"https://miscsubjects.com/a/tirzepatide-gabapentin"},{"slug":"tirzepatide-glp-1","title":"Tirzepatide for GLP-1 Contexts: Human Trial Data on Weight Loss and Load Reduction","url":"https://miscsubjects.com/a/tirzepatide-glp-1"},{"slug":"tirzepatide-glp1-agonists","title":"tirzepatide glp1 agonists","url":"https://miscsubjects.com/a/tirzepatide-glp1-agonists"},{"slug":"tirzepatide-glp1-gut","title":"Tirzepatide and GLP-1 Gut Damage / Gastroparesis: Evidence on Repair Layers vs Suppression Tradeoffs","url":"https://miscsubjects.com/a/tirzepatide-glp1-gut"},{"slug":"tirzepatide-gut","title":"Tirzepatide for Gut: Evidence on Microbiome, Motility, and Metabolic Load","url":"https://miscsubjects.com/a/tirzepatide-gut"},{"slug":"tirzepatide-herniated-disc","title":"Tirzepatide for Herniated Disc: Load Reduction and Layered Repair Pathways","url":"https://miscsubjects.com/a/tirzepatide-herniated-disc"},{"slug":"tirzepatide-ibd","title":"Tirzepatide for IBD (Crohn's / Colitis): What the Data Show on Load Reduction and Gut Pathways","url":"https://miscsubjects.com/a/tirzepatide-ibd"},{"slug":"tirzepatide-insomnia","title":"Tirzepatide for Insomnia: Weight Loss, OSA Data, and Sleep Evidence","url":"https://miscsubjects.com/a/tirzepatide-insomnia"},{"slug":"tirzepatide-metformin","title":"tirzepatide metformin","url":"https://miscsubjects.com/a/tirzepatide-metformin"},{"slug":"tirzepatide-muscle-loss","title":"Tirzepatide and Muscle Loss: Human Trial Data on Body Composition","url":"https://miscsubjects.com/a/tirzepatide-muscle-loss"},{"slug":"tirzepatide-nerve-damage","title":"Tirzepatide for Nerve Damage: Evidence-Graded Review","url":"https://miscsubjects.com/a/tirzepatide-nerve-damage"},{"slug":"tirzepatide-neuropathy","title":"Tirzepatide for Neuropathy: Metabolic Load Reduction and Observed Nerve Changes","url":"https://miscsubjects.com/a/tirzepatide-neuropathy"},{"slug":"tirzepatide-nsaids","title":"Tirzepatide for NSAIDs: Evidence on Load Reduction vs Signal Suppression","url":"https://miscsubjects.com/a/tirzepatide-nsaids"},{"slug":"tirzepatide-ozempic-face","title":"Tirzepatide for GLP-1 Facial Collagen Loss: A Data-First Evidence Review","url":"https://miscsubjects.com/a/tirzepatide-ozempic-face"},{"slug":"tirzepatide-plantar-fasciitis","title":"Tirzepatide for Plantar Fasciitis: Weight-Loss Load Reduction Evidence","url":"https://miscsubjects.com/a/tirzepatide-plantar-fasciitis"},{"slug":"tirzepatide-post-surgery","title":"Tirzepatide After Surgery: Evidence on Weight Loss, Load Reduction, and Recovery Pathways","url":"https://miscsubjects.com/a/tirzepatide-post-surgery"},{"slug":"tirzepatide-postherpetic","title":"Tirzepatide for Postherpetic Neuralgia: Weight Loss, Mechanical Load, and Evidence Review","url":"https://miscsubjects.com/a/tirzepatide-postherpetic"},{"slug":"tirzepatide-ppis","title":"Tirzepatide and PPIs: Metabolic Load Reduction While Managing Acid Suppression","url":"https://miscsubjects.com/a/tirzepatide-ppis"},{"slug":"tirzepatide-sciatica","title":"Tirzepatide for Sciatica: Load Reduction and Multi-Layer Repair Pathways","url":"https://miscsubjects.com/a/tirzepatide-sciatica"},{"slug":"tirzepatide-semaglutide","title":"Tirzepatide versus Semaglutide: Evidence-Graded Comparison on Weight Loss Pathways","url":"https://miscsubjects.com/a/tirzepatide-semaglutide"},{"slug":"tirzepatide-skin","title":"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions","url":"https://miscsubjects.com/a/tirzepatide-skin"},{"slug":"tirzepatide-statins","title":"tirzepatide statins","url":"https://miscsubjects.com/a/tirzepatide-statins"},{"slug":"tirzepatide-stimulants","title":"Tirzepatide and Peptides for Stimulant Load: Evidence on Semax, Selank, DSIP, and Adderall Cross","url":"https://miscsubjects.com/a/tirzepatide-stimulants"},{"slug":"tirzepatide-tendon","title":"Tirzepatide for Tendon Issues: Load Reduction, Inflammation, and Evidence Gaps","url":"https://miscsubjects.com/a/tirzepatide-tendon"},{"slug":"tirzepatide-tirzepatide","title":"Tirzepatide Evidence: Metabolic Load Reduction and Weight-Loss Pathways","url":"https://miscsubjects.com/a/tirzepatide-tirzepatide"},{"slug":"tirzepatide-trigeminal","title":"Tirzepatide for Trigeminal Issues: Metabolic Load Evidence Review","url":"https://miscsubjects.com/a/tirzepatide-trigeminal"}],"machine_side":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/voxels","discourse":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/discourse","append_protocol":"https://miscsubjects.com/a/append-protocol","protocol_door":"https://miscsubjects.com/api/protocol"},"slug":"tirzepatide-carpal-tunnel","div_mode":true,"voxel":{"mode":"div","divided_at":"2026-07-17T02:43:14.168Z","divided_by":"owner","original_body_sha":"07348f99498247f0c56dd76ce8f8740a47d680aeb55730c9fdcc509f5a0398c7","atoms":21,"version":1},"divs":[{"id":"d1","kind":"h","type":null,"order":1,"text":"## What's breaking down if you have Carpal tunnel syndrome","status":"active","vx_hash":"97fa0d05796e2743e893a14ccd7e3f6c18f602588f14780d1225a8627274907b","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"2646c645bfffbdb5eb90b8dcf7c36f7426db9b11713bc06a2f90d7fa58e5b653","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"c209f65ef58bec65a3bf006fe6fc62189e900bbe5b6b71d894c8679b36e352ce","detail":{"divided_from":"body","block":1,"kind":"h"},"prev":"genesis","hash":"2646c645bfffbdb5eb90b8dcf7c36f7426db9b11713bc06a2f90d7fa58e5b653"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d1"},{"id":"d2","kind":"p","type":null,"order":2,"text":"Carpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel at the wrist. Excess body weight increases mechanical pressure on soft tissues and can promote fluid retention or inflammation that narrows the tunnel further. Obesity correlates with higher CTS prevalence in multiple observational datasets. Metabolic factors tied to higher body mass may add to local swelling around tendons and the nerve sheath. The condition persists when tissue breakdown or ongoing compression outpaces any natural repair processes in the nerve and surrounding structures.","status":"active","vx_hash":"6f908cb582d039880fcd8c8e7724d4dfe09af95b733f15ac5e28e68eab73ce8e","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"3757e0748d44efb76e51ba86a6475966203ea7c2d28a16c3610ecd7d4a9fda37","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"3ca4124820f8275917f6c94c4f2f48e67e4a83a514d19357223db1e546dea01a","detail":{"divided_from":"body","block":2,"kind":"p"},"prev":"genesis","hash":"3757e0748d44efb76e51ba86a6475966203ea7c2d28a16c3610ecd7d4a9fda37"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d2"},{"id":"d3","kind":"h","type":null,"order":3,"text":"## Why Tirzepatide might help you","status":"active","vx_hash":"5b7f6a9b12576569af69fe0b0f4d595ed1e452661d893d59a1c1893c375958f1","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"329aefa4fa198821acedb740e887f1706949a071badae9c486f1b765ee0f7c94","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"5848fc9e672206442d3c6b12bd9fedecd777456f7c09c177771cecfd7caa2956","detail":{"divided_from":"body","block":3,"kind":"h"},"prev":"genesis","hash":"329aefa4fa198821acedb740e887f1706949a071badae9c486f1b765ee0f7c94"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d3"},{"id":"d4","kind":"list","type":null,"order":4,"text":"1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\n2. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\n3. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\n4. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.","status":"active","vx_hash":"6ac2f8dcaf673d74446f3920153d167448bf9a03c56089f30328762764fff2ce","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"7f91571c17eee351fe66c38eda2ecfa966f5630199b177d136e3b86caaf06295","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"c35ff9b654ecb2e055fbec3a99d5e26c9165be85df79f7f709fb6aef31960ada","detail":{"divided_from":"body","block":4,"kind":"list"},"prev":"genesis","hash":"7f91571c17eee351fe66c38eda2ecfa966f5630199b177d136e3b86caaf06295"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d4"},{"id":"d5","kind":"p","type":null,"order":5,"text":"If higher body weight contributes to wrist compression in your case, tirzepatide-driven weight reduction lowers overall mass pressing on tissues. Each pound lost reduces distributed load on joints and nerves in a manner similar to documented spinal compressive changes. This shifts the balance toward less ongoing mechanical stress rather than symptom suppression alone. Tirzepatide does not act directly on nerve conduction or local inflammation in published data; any benefit would flow through sustained body-weight reduction.","status":"active","vx_hash":"9a7defe275d51be2c694048e3064c719883d9382bdbf031a79f53258ae3bcd59","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"c1609dec9f03a59b7a6ea9c5e8d41bfdea6ca8190ca905bf73fa2f6da1aaa6e1","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"450e341f15a7bcc3f948e218525fcd040c6af4dbc4db5a49454a2e33cb08e315","detail":{"divided_from":"body","block":5,"kind":"p"},"prev":"genesis","hash":"c1609dec9f03a59b7a6ea9c5e8d41bfdea6ca8190ca905bf73fa2f6da1aaa6e1"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d5"},{"id":"d6","kind":"h","type":null,"order":6,"text":"## How these fit together","status":"active","vx_hash":"99fa34fe0f184df15245bdd6179287e2495609255e55f79e62028fefb3b6a674","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"2d0210321a5d14b2fb28a526b0f6ace63b6fdd81aa79016082d5faf931855946","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"255677f13849515d0e42f067e34911236d8b3298d6c16100bfa19e68c3074d62","detail":{"divided_from":"body","block":6,"kind":"h"},"prev":"genesis","hash":"2d0210321a5d14b2fb28a526b0f6ace63b6fdd81aa79016082d5faf931855946"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d6"},{"id":"d7","kind":"p","type":null,"order":7,"text":"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.","status":"active","vx_hash":"e9d5c983dc2010eb61dccb3bf3f2b835ae7b79b18f81d35093c428f4f2711c42","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"3ed004fd87c431c5ddf854603a4ab70765940932205f3776f41dd43f6adeb194","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"c2ad98828fc97845a2d8301bcbb28499a499eca01d27b8754f58a5bd039ad6e9","detail":{"divided_from":"body","block":7,"kind":"p"},"prev":"genesis","hash":"3ed004fd87c431c5ddf854603a4ab70765940932205f3776f41dd43f6adeb194"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d7"},{"id":"d8","kind":"list","type":null,"order":8,"text":"- **Tirzepatide** → metabolic load / body weight","status":"active","vx_hash":"9f002b285971d4ff961ec629f3e922c2aee9d83145fd568fd785d2cba90fc9a9","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"2c668a4583131283d6f03250589154d9e831f8ec6bfecbf5989c46d8b0421447","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"8af7ff8716f14ab59eca45762fe947b922c661a1ac6462d47d8549554a2fc11f","detail":{"divided_from":"body","block":8,"kind":"list"},"prev":"genesis","hash":"2c668a4583131283d6f03250589154d9e831f8ec6bfecbf5989c46d8b0421447"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d8"},{"id":"d9","kind":"p","type":null,"order":9,"text":"Tirzepatide addresses only the metabolic-load layer here. No additional compounds appear in scope, so the discussion stays on weight-mediated changes to tissue pressure.","status":"active","vx_hash":"0a475bc0c336860e80e59dd453c925ebb048e3891b512692ec50b5338fae3e60","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"cd80db8ab3499165bed80664a729cee8c7b6c078b594731c363a37f39a09d15f","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"2c99a33cf130ec8a1fba51999c3be589671a120a48f66883a7e21c725e506275","detail":{"divided_from":"body","block":9,"kind":"p"},"prev":"genesis","hash":"cd80db8ab3499165bed80664a729cee8c7b6c078b594731c363a37f39a09d15f"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d9"},{"id":"d10","kind":"h","type":null,"order":10,"text":"## What the evidence actually shows","status":"active","vx_hash":"1f3addc2ca983d5d128712ff3d49b6582606c543a6cf9b89cb4a27314cd8110c","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"b876e2ec9f698455c1210f7a47f9b5282a9b8598b1e22ed467d6606676572133","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"a7a051e6a294dc45c15b7d4859b7020d561e719fe73844f03e3a8f9e7fed8de1","detail":{"divided_from":"body","block":10,"kind":"h"},"prev":"genesis","hash":"b876e2ec9f698455c1210f7a47f9b5282a9b8598b1e22ed467d6606676572133"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d10"},{"id":"d11","kind":"p","type":null,"order":11,"text":"Human data on weight loss and CTS come from observational studies and bariatric-surgery cohorts rather than randomized trials of tirzepatide. One 2008 study followed obese CTS patients after weight loss and found no statistically significant improvement in median-nerve conduction velocities despite BMI reduction (human, n not specified in abstract). A 2009 bariatric-surgery series of 43 patients reported symptom resolution in all but three after ≥50 lb loss (human observational). A 2024 analysis linked bariatric weight loss to lower subsequent CTS risk in obese populations (human). No published human trials test tirzepatide specifically for CTS. One 2024 case series noted peroneal-nerve foot drop after rapid tirzepatide-assisted loss, illustrating that swift weight change can sometimes affect peripheral nerves (human, small series). Preclinical data on tirzepatide and nerve compression are absent from searches. Anecdotal reports on forums describe mixed outcomes: some note CTS symptom easing after weight drop on tirzepatide; others report new or persistent hand tingling.","status":"active","vx_hash":"dad6f3e2ee1fe452cb7d594e5d61f2a2303e7888f9c4fc333ca5ae238970605b","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"9ef88aa5cfb0a369fd3a24c2977342a03073315237faa9d33d8cfa3b0e22b012","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"e9ee9c0761f0e5cbe353943d6615b3b33cf14309b66ed924d5ebbb8132329193","detail":{"divided_from":"body","block":11,"kind":"p"},"prev":"genesis","hash":"9ef88aa5cfb0a369fd3a24c2977342a03073315237faa9d33d8cfa3b0e22b012"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d11"},{"id":"d12","kind":"h","type":null,"order":12,"text":"## What scientists say","status":"active","vx_hash":"80ab84d69b7b292d1a6ba46fd6fddc4809486f9920cd37e07384a5a461dc1902","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"da80f9e9f6ae5df9e3c723df6720be7e4226f7032d4a1cacb310369e50d94396","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"2f1dd55083de1fa734f2f06a8337a050d5a0b3f635bfc8bb709abab75705a1ef","detail":{"divided_from":"body","block":12,"kind":"h"},"prev":"genesis","hash":"da80f9e9f6ae5df9e3c723df6720be7e4226f7032d4a1cacb310369e50d94396"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d12"},{"id":"d13","kind":"p","type":null,"order":13,"text":"Researchers note obesity as a modifiable CTS risk factor and suggest weight reduction may lessen symptoms by decreasing tissue pressure and associated metabolic burden (human observational tier). They caution that weight loss alone does not reliably normalize nerve conduction or eliminate all cases, pointing to multifactorial causes including repetitive strain and individual anatomy. No statements tie tirzepatide directly to CTS repair pathways.","status":"active","vx_hash":"76b5fa4882b36e677c16d728d9dfe3900aaccb63bcefd2f93cbead2ffa2f2101","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"725f9b166389c301beb15c47d4cfbd9c5f731781d721fae35d09210712f88ebf","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"58b78d07a84aaf04e2234d642f49acefc41b52137ec3bf06083c94bf59383d07","detail":{"divided_from":"body","block":13,"kind":"p"},"prev":"genesis","hash":"725f9b166389c301beb15c47d4cfbd9c5f731781d721fae35d09210712f88ebf"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d13"},{"id":"d14","kind":"h","type":null,"order":14,"text":"## What people say on Reddit","status":"active","vx_hash":"a871b6b95ad5d80b8257ef85d2566ca1033fb8b238c1fc584e21ec7862fabeb5","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"57329aae9bc7cec3414bc4b78fe1c254cee243cf8a5e5ebe6f146240c9fb4d97","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"feb303756a303788527cf602bf2c3c6b00ab8c384fb9fff4baa9ffc53e0049c3","detail":{"divided_from":"body","block":14,"kind":"h"},"prev":"genesis","hash":"57329aae9bc7cec3414bc4b78fe1c254cee243cf8a5e5ebe6f146240c9fb4d97"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d14"},{"id":"d15","kind":"p","type":null,"order":15,"text":"Users on r/Zepbound and r/Mounjaro report variable hand symptoms. Several describe reduced nighttime pins-and-needles or improved grip after substantial weight loss on the medication, attributing changes to decreased overall swelling. Others mention new or unchanged tingling that they or their clinicians link to carpal tunnel, sometimes questioning whether rapid loss contributed. These remain individual anecdotes without controlled comparison (anecdotal tier).","status":"active","vx_hash":"0b25b6b5d0c2f6ccd4017678e05893b075c63d842843ecaea0ebb5487e58e1e1","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"595b0ac7ad81b263d5de9c80cccc25e3b8ff70d21b23f3bef260c5a866900666","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"4c89bc07a2c44941b41b08a1ebe96ab84d08318dfca9f490ccc80e87aa404710","detail":{"divided_from":"body","block":15,"kind":"p"},"prev":"genesis","hash":"595b0ac7ad81b263d5de9c80cccc25e3b8ff70d21b23f3bef260c5a866900666"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d15"},{"id":"d16","kind":"h","type":null,"order":16,"text":"## What people say on X","status":"active","vx_hash":"ef96ee53980ca04c79bf52826a8be90deb4eba0f4e6db8501359f68bf75a3aed","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"825821020c0b11563e7ce04703111b5584b6006d41489385edd760287441d7a3","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"4dd8bbfdb0452cc6235c2300209b5132daba3913b8f54ab179b1a73109c298dd","detail":{"divided_from":"body","block":16,"kind":"h"},"prev":"genesis","hash":"825821020c0b11563e7ce04703111b5584b6006d41489385edd760287441d7a3"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d16"},{"id":"d17","kind":"p","type":null,"order":17,"text":"Public posts on X mirror forum patterns: occasional mentions of CTS improvement coinciding with tirzepatide weight loss, alongside isolated reports of new neuropathy symptoms during rapid reduction. No large-scale user surveys appear in results.","status":"active","vx_hash":"b996a4a4ea122cfd3d08dfeb8f36fe7d2255449252cec18d4b82985f34f13a4c","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"e38a3193f0d0583f54d1a98e0d12c2b89da7c4a4e6e17287ad1081d82d59e549","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"8bb042ca806a0b7dcb30eb2f99c854b1605f138d85729cd27812f4feddb2eb55","detail":{"divided_from":"body","block":17,"kind":"p"},"prev":"genesis","hash":"e38a3193f0d0583f54d1a98e0d12c2b89da7c4a4e6e17287ad1081d82d59e549"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d17"},{"id":"d18","kind":"h","type":null,"order":18,"text":"## What we do not know","status":"active","vx_hash":"99c933824e392c483b6ce111fb3cd459e5b9838a53547db4ae321fd5df8560df","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"a35f0ba6229b77c5506ec91bb0aa5557ab7386bd30f57d8efcbea21632433b70","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"7d96a49fba77f6a48c0321db2ae4180a902beae62e2aac0d23408fbf8333a177","detail":{"divided_from":"body","block":18,"kind":"h"},"prev":"genesis","hash":"a35f0ba6229b77c5506ec91bb0aa5557ab7386bd30f57d8efcbea21632433b70"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d18"},{"id":"d19","kind":"p","type":null,"order":19,"text":"Direct human trials measuring tirzepatide effects on CTS electrodiagnostics or symptom scores are unavailable. The precise contribution of GLP-1/GIP agonism versus weight loss itself remains unseparated. Long-term durability of any CTS changes after tirzepatide discontinuation is undocumented. Interactions with other CTS contributors such as repetitive hand use or diabetes-related neuropathy lack specific study.","status":"active","vx_hash":"49034f77a6db899421832f7c57a8cb188d29d8fcc2873caa5f3f14c8d52391a7","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"947d6bfc7f5b665813bbffb00173b6e882d3059c8127d0279ef50f8c4a3f7abb","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"a63231863ed3a0ec49658523f1cb154d9f7241b6dee8a0eb9093363a5d44a8f5","detail":{"divided_from":"body","block":19,"kind":"p"},"prev":"genesis","hash":"947d6bfc7f5b665813bbffb00173b6e882d3059c8127d0279ef50f8c4a3f7abb"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d19"},{"id":"d20","kind":"h","type":null,"order":20,"text":"## Safety and limits","status":"active","vx_hash":"0eb4424af6efaf9fa96130004e7522ae54ba8b30fbffabd6d4a8fad46b658d2e","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"c147f71fd5df1ca7bd4bed83449cc63db9362382ccac3229c028bac8c907c516","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"404f7427c043c6ec7a5cb4416bbec9ec336e19f8757fb217be5c5c2161ff8cb6","detail":{"divided_from":"body","block":20,"kind":"h"},"prev":"genesis","hash":"c147f71fd5df1ca7bd4bed83449cc63db9362382ccac3229c028bac8c907c516"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d20"},{"id":"d21","kind":"p","type":null,"order":21,"text":"Tirzepatide carries documented gastrointestinal side effects and rare reports of neuropathy after rapid loss. Any consideration of the medication occurs outside labeled indications for CTS. Evidence reviewed here is graded by tier and does not constitute guidance. Individual responses vary; clinical evaluation remains necessary for persistent nerve symptoms.","status":"active","vx_hash":"bd17ebc9a3c59b088bc2342001669de134ff50eb78dfb2f6889dfa234f48163f","semantic_hash":null,"version_hash":null,"version":1,"sources":[],"falsifiers":[],"tier":null,"backed":null,"transcludes":null,"chain_head":"aee9f5e6c3489aca7e92899f522259a508166b20b77ef1cf2f9fc3abe1ea9e5e","chain_length":1,"chain":[{"n":1,"op":"genesis","ts":"2026-07-17T02:43:14.168Z","actor":"owner","text_sha":"a7964024c4fef1256677866bb280b9e4b048a7ee6b96e8b475d42f7fb91de79e","detail":{"divided_from":"body","block":21,"kind":"p"},"prev":"genesis","hash":"aee9f5e6c3489aca7e92899f522259a508166b20b77ef1cf2f9fc3abe1ea9e5e"}],"claim_ids":[],"last_op":{"op":"genesis","actor":"owner","ts":"2026-07-17T02:43:14.168Z"},"consolidated_into":null,"stable_url":"https://miscsubjects.com/i/div/tirzepatide-carpal-tunnel/d21"}],"voxels":[{"id":"c1","div_id":"claim:c1","kind":"claim","text":"Obesity increases risk of carpal tunnel syndrome and weight loss is associated with symptom improvement in some observational human cohorts.","tier":"human","standing":null,"weight":0.8,"section":"What's breaking down if you have Carpal tunnel syndrome","status":"active","source_ids":["s1","s2","s3"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"supported_by","target":"s1","source_type":"pubmed","hash":"58df7e66b4eb921b"},{"type":"supported_by","target":"s2","source_type":"news","hash":"70f8e03d8beff0af"},{"type":"supported_by","target":"s3","source_type":"pubmed","hash":"e994fb136d01e03d"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z"}],"why_material":"Establishes mechanical-load layer relevant to tirzepatide discussion","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/tirzepatide-carpal-tunnel/c1","machine_url":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/claims/c1"},{"id":"c2","div_id":"claim:c2","kind":"claim","text":"No randomized human trials exist for tirzepatide in carpal tunnel syndrome.","tier":"human","standing":null,"weight":0.8,"section":"What the evidence actually shows","status":"active","source_ids":["s4"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"supported_by","target":"s4","source_type":"other","hash":"07c49f3d9306ba35"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z"}],"why_material":"Clarifies evidence gap for single-compound focus","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/tirzepatide-carpal-tunnel/c2","machine_url":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/claims/c2"},{"id":"c3","div_id":"claim:c3","kind":"claim","text":"Rapid tirzepatide-associated weight loss has been linked in one small human case series to peroneal neuropathy.","tier":"human","standing":null,"weight":0.8,"section":"What the evidence actually shows","status":"active","source_ids":["s5","s4"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"supported_by","target":"s5","source_type":"other","hash":"e612c550c1b4a979"},{"type":"supported_by","target":"s4","source_type":"other","hash":"07c49f3d9306ba35"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z"}],"why_material":"Highlights potential nerve effects of swift mass reduction","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/tirzepatide-carpal-tunnel/c3","machine_url":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/claims/c3"},{"id":"c4","div_id":"claim:c4","kind":"claim","text":"Reddit users report both improvement and new onset of hand symptoms while using tirzepatide or similar GLP-1 agents.","tier":"anecdotal","standing":null,"weight":0.3,"section":"What people say on Reddit","status":"active","source_ids":["s6","s7"],"source_status":"sourced","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z","model":"grok/grok-4.3","rationale":""},"who_claims":"grok/grok-4.3","edges":[{"type":"supported_by","target":"s6","source_type":"reddit","hash":"5663337c1855825f"},{"type":"supported_by","target":"s7","source_type":"reddit","hash":"35267365ecfd1e51"},{"type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z"}],"why_material":"Captures real-world user observations separate from trials","content_hash":null,"stable_url":"https://miscsubjects.com/i/claim/tirzepatide-carpal-tunnel/c4","machine_url":"https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/claims/c4"}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18264014/","title":"Obesity and carpal tunnel syndrome: is there a causal relationship?","quote":"Obesity is defined as a risk factor for carpal tunnel syndrome (CTS).","summary":"2008 human study on weight loss and nerve conduction in CTS patients.","claim_ids":["c1"],"found_by":"grok/grok-4.3","hash":"58df7e66b4eb921b53fccacce05bb52b278ecad8424abebc87a068813eabd9b0","prev":"genesis"},{"id":"s2","type":"news","url":"https://www.sciencedaily.com/releases/2009/10/091025194759.htm","title":"Weight Loss Can Shed Pounds And Carpal Tunnel","quote":"After weight loss of 50 pounds or more, all but 3 patients reported a resolution of symptoms.","summary":"2009 bariatric surgery cohort showing CTS symptom resolution post-massive weight loss.","claim_ids":["c1"],"found_by":"grok/grok-4.3","hash":"70f8e03d8beff0af739d286f33e7ebec4d692bd6afa5c26e7eaaefad002ff515","prev":"58df7e66b4eb921b53fccacce05bb52b278ecad8424abebc87a068813eabd9b0"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18264014/","title":"Obesity and carpal tunnel syndrome","quote":"We expected a recovery in median nerve conduction velocities in patients with CTS after weight loss.","summary":"Details lack of conduction-velocity recovery despite BMI drop.","claim_ids":["c1"],"found_by":"grok/grok-4.3","hash":"e994fb136d01e03db40fa519dcd63088d0e5b5e55c83e53de35f79e10ebc3eaa","prev":"70f8e03d8beff0af739d286f33e7ebec4d692bd6afa5c26e7eaaefad002ff515"},{"id":"s4","type":"other","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11273815/","title":"The Tirzepatide Drop: Beware of Slimmer's Paralysis","quote":"This case series explores the association between tirzepatide-assisted weight loss and the development of foot drop due to peroneal nerve neuropathy.","summary":"2024 human case series on rapid-loss neuropathy.","claim_ids":["c2","c3"],"found_by":"grok/grok-4.3","hash":"07c49f3d9306ba35d44fcf428c38fbbcad125675d9706f24be4b6d0eb260a842","prev":"e994fb136d01e03db40fa519dcd63088d0e5b5e55c83e53de35f79e10ebc3eaa"},{"id":"s5","type":"other","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11273815/","title":"The Tirzepatide Drop","quote":"association between tirzepatide-assisted weight loss and the development of foot drop","summary":"Documents peripheral-nerve event after tirzepatide weight loss.","claim_ids":["c3"],"found_by":"grok/grok-4.3","hash":"e612c550c1b4a9796e3d0b9e50e963c1578e3b6da144764271620420b7e8aa5f","prev":"07c49f3d9306ba35d44fcf428c38fbbcad125675d9706f24be4b6d0eb260a842"},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/Zepbound/comments/1nnl80t/zepbound_and_carple_tunnel_syndrome/","title":"Zepbound and Carple tunnel syndrome","quote":"I have diagnosed carpal tunnel syndrome, but since I've lost weight it has gotten much better.","summary":"User anecdote of CTS improvement with Zepbound weight loss.","claim_ids":["c4"],"found_by":"grok/grok-4.3","hash":"5663337c1855825f536e7ebaf9937e7110634325d52c0eaca79bd84602008ec9","prev":"e612c550c1b4a9796e3d0b9e50e963c1578e3b6da144764271620420b7e8aa5f"},{"id":"s7","type":"reddit","url":"https://www.reddit.com/r/Zepbound/comments/1gqvgu5/tinglingnumbnessweakness_in_hands_5mg/","title":"Tingling/Numbness/Weakness in hands 5mg","quote":"Zepbound or a condition created by Zepbound and not some newly undiagnosed condition (ie MS, Neuropathy, Carpal Tunnel","summary":"User discussion of possible new CTS-like symptoms on medication.","claim_ids":["c4"],"found_by":"grok/grok-4.3","hash":"35267365ecfd1e51b0ba9bd87e1a0d10400f1dbcfc962635311df3a9d3fd6b9c","prev":"5663337c1855825f536e7ebaf9937e7110634325d52c0eaca79bd84602008ec9"}],"edges":[{"from":"c1","type":"supported_by","target":"s1","source_type":"pubmed","hash":"58df7e66b4eb921b"},{"from":"c1","type":"supported_by","target":"s2","source_type":"news","hash":"70f8e03d8beff0af"},{"from":"c1","type":"supported_by","target":"s3","source_type":"pubmed","hash":"e994fb136d01e03d"},{"from":"c1","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z"},{"from":"c2","type":"supported_by","target":"s4","source_type":"other","hash":"07c49f3d9306ba35"},{"from":"c2","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z"},{"from":"c3","type":"supported_by","target":"s5","source_type":"other","hash":"e612c550c1b4a979"},{"from":"c3","type":"supported_by","target":"s4","source_type":"other","hash":"07c49f3d9306ba35"},{"from":"c3","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z"},{"from":"c4","type":"supported_by","target":"s6","source_type":"reddit","hash":"5663337c1855825f"},{"from":"c4","type":"supported_by","target":"s7","source_type":"reddit","hash":"35267365ecfd1e51"},{"from":"c4","type":"posted_by","actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T22:51:56.715Z"}],"counts":{"divs":21,"voxels":4,"sources":7,"edges":12},"verification":{"div_mode":true,"divs":21,"all_chains_valid":true,"body_matches_divs":true,"per_div":[{"id":"d1","order":1,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d2","order":2,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d3","order":3,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d4","order":4,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d5","order":5,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d6","order":6,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d7","order":7,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d8","order":8,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d9","order":9,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d10","order":10,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d11","order":11,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d12","order":12,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d13","order":13,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d14","order":14,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d15","order":15,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d16","order":16,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d17","order":17,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d18","order":18,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d19","order":19,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d20","order":20,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]},{"id":"d21","order":21,"status":"active","chain_valid":true,"content_hash_valid":true,"chain_length":1,"breaks":[]}]},"procedure":{"what":"Every article has a human side (/a/tirzepatide-carpal-tunnel) and a machine side (this endpoint). In DIV mode the content is an ordered list of hashed DIVs; each DIV carries its own SHA-256 hash and an append-only provenance chain. Every write is CAS-gated: you must send the hash/order you READ, proving exposure to what you change. Every successful write returns a clickable human permalink.","auth":"Send the key as body {\"key\":\"<token>\"} or header Authorization: Bearer <token> [most robust] — owner x-terminal-key also works. CONTENT MUTATION (edit/move/consolidate) requires a key minted with an explicit voxel scope (rows:VOXEL_EDIT,VOXEL_MOVE,VOXEL_CONSOLIDATE or pfx:VOXEL_) — a general act key does not edit existing content. Filing a challenge or attestation needs no key at all.","web_runtime":"WEB CHATGPT: open https://miscsubjects.com/api/model-lane first. Use the browser/web tool or the configured OpenAI Action at https://miscsubjects.com/api/openai/actions.json. Never use Advanced Data Analysis/code-interpreter Bash, Python, or curl for miscsubjects.com. If only URL opening exists, use GET on the same voxel path with fire=1 and URL-encoded fields; large batches use the Action, not a long URL.","divide":"POST https://miscsubjects.com/api/protocol/voxel-divide {\"slug\":\"tirzepatide-carpal-tunnel\",\"key\":\"<token>\"} — atomize the body into DIVs (verbatim, roundtrip-checked, idempotent). act scope suffices; content is unchanged by dividing.","edit":"POST https://miscsubjects.com/api/protocol/voxel-edit {\"slug\":\"tirzepatide-carpal-tunnel\",\"div_id\":\"d3\",\"expected_hash\":\"<that div's CURRENT vx_hash>\",\"text\":\"<new verbatim text>\",\"actor\":\"<your model name>\",\"key\":\"<voxel-scoped token>\"} — stale hash → 409 hash_stale with the current text+hash.","move":"POST https://miscsubjects.com/api/protocol/voxel-move {\"slug\":\"tirzepatide-carpal-tunnel\",\"div_id\":\"d3\",\"expected_order\":<current order>,\"direction\":\"up|down\",\"key\":\"<voxel-scoped token>\"} — stale order → 409 order_stale with the current layout.","consolidate":"POST https://miscsubjects.com/api/protocol/voxel-consolidate {\"slug\":\"tirzepatide-carpal-tunnel\",\"div_ids\":[\"d3\",\"d4\"],\"expected_hashes\":[\"<d3 hash>\",\"<d4 hash>\"],\"text\":\"<optional merged text>\",\"actor\":\"<model>\",\"key\":\"<voxel-scoped token>\"}","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {\"slug\":\"tirzepatide-carpal-tunnel\",\"expected_thread_head\":\"<thread_head from /discourse>\",\"target_div\":\"d3\",\"expected_hash\":\"<d3 hash>\",\"stance\":\"challenge|support|upgrade\",\"body\":\"<steelmanned objection>\",\"actor\":\"<model>\"} — open intake, no key needed. Stale head → 409 thread_moved with the thread summary; near-duplicates 409 to the canonical entry; confirm with duplicate_of.","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {\"slug\":\"tirzepatide-carpal-tunnel\",\"outcome\":\"novel_objection|duplicate_confirm|upgrade_proposal|nothing_to_add\",\"content_hash\":\"<the body sha you read>\",\"actor\":\"<model>\"} — the four-outcome close of a keyed read. A norm, not a lock: reading stays free; only an artifact proves reading.","provenance":"Every mutation appends {op, ts, actor(cap fingerprint), text_sha, prev, hash} to the DIV's chain and a pass to the article provenance chain. Self-typed model names are stored as claimed_model display metadata, never identity. Verify: GET /api/articles/tirzepatide-carpal-tunnel/voxels — chains recomputed from genesis, never trusted.","batch":"POST https://miscsubjects.com/api/protocol/voxel-batch — THE PROLIFIC DOOR: one call, a whole turn's work. Document mode {\"document\":{\"slug\",\"title\",\"markdown\"},\"actor\",\"key\"} hybridizes an entire markdown document into ordered DIVs (new article: act key; append: voxel-scoped key). Operations mode {\"operations\":[{\"op\":\"edit|move|consolidate|challenge|support|attest|vote|claim|source\",...}],\"key\"} runs up to 300 ops with per-op receipts. Append your session's output to the ledger, not the chat. Format precedent: https://miscsubjects.com/a/append-protocol","vote":"POST https://miscsubjects.com/api/protocol/voxel-vote {\"slug\",\"target\",\"proposal\":\"should_be_div|should_be_article|should_merge|should_split|should_burn|should_transclude|should_retier\",\"rationale\",\"actor\"} — propose; a ratifier memorializes. POST https://miscsubjects.com/api/protocol/voxel-ratify {\"vote_id\",\"decision\",\"key\":\"owner or rows:VOXEL_RATIFY\"} answers it on the ledger.","burn":"POST https://miscsubjects.com/api/protocol/voxel-burn {\"ids\":[...]|\"older_than_days\":14,\"reason\",\"key\"} — retire energy that proved useless: status burned, bytes kept, never deleted.","discourse":"GET https://miscsubjects.com/api/articles/tirzepatide-carpal-tunnel/discourse — every filed objection/support/attestation, OPEN first. Human side renders the same index at /a/tirzepatide-carpal-tunnel#disc-<id>.","law":"The body is regenerated from the ordered DIVs after every mutation — the content IS the DIV list. Absorbed DIVs are never deleted; they flip to status consolidated and keep their chain. End a write turn by handing the human the link the response gives you."},"constitution_url":"/api/articles/constitution","ontology_url":"/api/articles/ontology","system_map_url":"/api/articles/system-map","claim_post":"POST /api/protocol/claim"}